Quadrature Capital LTD Guardant Health, Inc. Transaction History

Quadrature Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $911,317 - $2.45 Million	31,621 New	31,621 $1.28 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $420,402 - $875,569	-8,713 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $288,751 - $391,999	-3,255 Reduced 27.2%	8,713 $872,000
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $1.18 Million - $1.58 Million	11,968 New	11,968 $1.5 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $525,056 - $740,220	-4,133 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $988,304 - $1.34 Million	-9,887 Reduced 70.52%	4,133 $533,000
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $494,836 - $872,031	-7,906 Reduced 36.06%	14,020 $894,000
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $1.4 Million - $2 Million	21,926 New	21,926 $0

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.